GANX icon

Gain Therapeutics

24 hedge funds and large institutions have $4.95M invested in Gain Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding

Funds holding:

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

13% less capital invested

Capital invested by funds: $5.68M → $4.95M (-$725K)

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$54K
Puts
$20K
Net Calls
Net Calls Change

Top Buyers

1 +$623K
2 +$137K
3 +$41.2K
4
Citadel Advisors
Citadel Advisors
Florida
+$31.1K
5
Simplex Trading
Simplex Trading
Illinois
+$28K

Top Sellers

1 -$56.3K
2 -$14.7K
3 -$13.4K
4
TRCT
Tower Research Capital (TRC)
New York
-$4.84K
5
UBS Group
UBS Group
Switzerland
-$3.75K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.93M
2
$689K
3
$489K
4
$295K
5
$231K
6
$211K
7
$191K
8
$154K
9
$149K
10
$148K
11
$111K
12
$91.6K
13
$54.3K
14
$43.5K
15
$36.2K
16
$32.8K
17
$28K
18
$27.2K
19
$12.2K
20
$9.41K
21
$8.2K
22
$6.26K
23
$4.26K
24
$3.28K
25